Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches? (Q38183302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Heinrich J Huber

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ross G McKiernan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

30 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

227-237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-014-1126-5

6 March 2020

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Bistability analyses of a caspase activation model for receptor-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A mathematical model of caspase function in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Quantitative analysis of pathways controlling extrinsic apoptosis in single cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

APOPTO-CELL--a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Dynamics of outer mitochondrial membrane permeabilization during apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Approaches for targeting mitochondria in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Targeting mitochondria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Cancer gene therapy targeting cellular apoptosis machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Systems biology analysis of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mathematical modelling of the mitochondrial apoptosis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Systems biology of apoptosis and survival: implications for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Measuring and modeling apoptosis in single cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Targeting the B-cell lymphoma/leukemia 2 family in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

BCL-2 family antagonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Etoposide: four decades of development of a topoisomerase II inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Cetuximab for the treatment of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

21 January 2018

The BCL-2 family reunion

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A unified model of mammalian BCL-2 protein family interactions at the mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Ewing's sarcoma family of tumors: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mitochondria and cell death: outer membrane permeabilization and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Caspase-9 can be activated without proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Structural basis of IAP recognition by Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

c-Myc blazing a trail of death: coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Modeling a snap-action, variable-delay switch controlling extrinsic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Real-time single cell analysis of Smac/DIABLO release during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Bax directly induces release of cytochrome c from isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Targeting IAP proteins for therapeutic intervention in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Dexamethasone inhibits apoptosis in C6 glioma cells through increased expression of Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Dynamics within the CD95 death-inducing signaling complex decide life and death of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Heterogeneity reduces sensitivity of cell death for TNF-stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Exploring the contextual sensitivity of factors that determine cell-to-cell variability in receptor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Theoretical studies on the control of oxidative phosphorylation in muscle mitochondria: application to mitochondrial deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

The caspase-8 dimerization/dissociation balance is a highly potent regulator of caspase-8, -3, -6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1126-5

Systems analysis of cancer cell heterogeneity in caspase-dependent apoptosis subsequent to mitochondrial outer membrane permeabilization.

21 January 2018

1 reference

12 December 2020

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

12 December 2020

In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs

1 reference

12 December 2020

The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.

1 reference

12 December 2020

Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas

1 reference

12 December 2020

The indirect activation model of mitochondrial outer membrane permeabilisation (MOMP) initiation requires a trade-off between robustness in the absence of and sensitivity in the presence of stress

1 reference

12 December 2020

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

12 December 2020

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer

1 reference

12 December 2020

Targeting mitochondria for cancer therapy

1 reference

12 December 2020

The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy

1 reference

12 December 2020

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1 reference

12 December 2020

Mitochondria and neuronal survival

1 reference

12 December 2020

Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling.

1 reference

12 December 2020

PUMA and BIM are required for oncogene inactivation-induced apoptosis.

1 reference

12 December 2020

A structured approach to the study of metabolic control principles in intact and impaired mitochondria

1 reference

12 December 2020

Systems biology of apoptosis signaling networks

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020

10.1007/S00109-014-1126-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24477766%20AND%20SRC:MED&resulttype=core&format=json